On Thursday, March 27, 2014, Paul B. Rothman, M.D., the dean of the medical faculty and CEO of Johns Hopkins Medicine, participated in a panel discussion as part of a larger health care forum organized by The Atlantic called "Health Care Tomorrow: Examining the Tools and Technologies that Will Revolutionize the Future Health Care System.”
Dr. Rothman and his fellow panelists outlined a promising future for health care, where technology supplements traditional care and allows patients and doctors to make more informed care decisions. Some of the innovations they discussed, like electronic medical records, are already being implemented in health systems across the country.
According to Dr. Rothman, health care technology has the potential to elevate patient care by creating treatment approaches that are not only cheaper but are also tailored to patients’ unique genetic makeup. “I think the promise of electronic medical records and other technologies will be our ability to find subsets of diseases.”
“As we learn how to use genetic information, better histories, better imaging techniques and better tests, we’re going to be able to find subsets of diseases and targeted therapies in a much more efficient manner,” said Dr. Rothman.
Even before these advancements are made, electronic medical records will have immediate payoffs for patients and health systems. Electronic medical records give patients greater control of their health information and help physicians provide more coordinated care.
Although excited about the future of health care technology, Dr. Rothman expressed concern that the emphasis on technological devices could lead some doctors to spend less time with their patients. He called patient-physician interaction “essential for care” and later reminded the panel that regardless of the technology available, “we have to get out of our hospitals and get into the communities.”
In addition to Dr. Rothman, panelists included Ed Park, the executive vice president and COO of athenahealth, Dr. Roger Ray, the executive vice president and chief medical officer of Carolinas Healthcare System and John Castellani, the president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA). Dr. James Hamblin, health editor at The Atlantic, moderated the panel discussion.
Visit The Atlantic for more information.
About Paul B. Rothman, M.D.
Dr. Rothman is the Dean of the Medical Faculty and CEO of Johns Hopkins Medicine. View his profile.
About Johns Hopkins Medicine
JHM unites the physicians and scientists of the School of Medicine with the health professionals and facilities that make up the broad, integrated Johns Hopkins Health System. Learn more.